X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

TRANSFUSION MEDICINE AND HEMOTHERAPY

期刊標題檢索 TRANSFUS MED HE 最新評論: Research Focus: Blood transfusion experience sharing: How long does i... (2023-03-11)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[TRANSFUSION MEDICINE AND HEMOTHERAPY]您好,您是該頁面的第 11207 位訪客。

期刊簡介
期刊名稱TRANSFUSION MEDICINE AND HEMOTHERAPY TRANSFUSION MEDICINE AND HEMOTHERAPY
LetPub Score
6.2
50 ratings
Rate

Reputation
7.6

Influence
4.9

Speed
7.1

期刊簡稱TRANSFUS MED HEMOTH
ISSN1660-3796
E-ISSN1424-5493
h-index33
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.000.5821.143
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Hematology
Q269 / 137
Category: Medicine
Subcategory: Immunology and Allergy
Q3142 / 233

自引率 (2023-2024)5.30%自引率趨勢
掲載範囲
This journal is devoted to all areas of transfusion medicine. These include the quality and security of blood products, therapy with blood components and plasma derivatives, transfusion-related questions in transplantation, stem cell manipulation, therapeutic and diagnostic problems of homeostasis, immuno-hematological investigations, and legal aspects of the production of blood products as well as hemotherapy. Both comprehensive reviews and primary publications that detail the newest work in transfusion medicine and hemotherapy promote the international exchange of knowledge within these disciplines. Consistent with this goal, continuing clinical education is also specifically addressed.
官方網站http://www.karger.com/Journal/Home/224170
在線稿件提交http://www.karger.com/Journal/Guidelines/224170
開放訪問No
出版商S. Karger AG
主題領域医学
出版國/地區SWITZERLAND
發行頻率隔月刊行
創刊年2003
每年文章數53每年文章數趨勢
黃金OA百分比92.62%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
HEMATOLOGYSCIEQ364/97
IMMUNOLOGYSCIEQ4146/181
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1660-3796%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【TRANSFUSION MEDICINE AND HEMOTHERAPY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    NATURE IMMUNOLOGYH-index: 344

    CiteScore: 40.00
    Annual Review of ImmunologyH-index: 279

    CiteScore: 57.20
    ImmunityH-index: 355

    CiteScore: 49.40
    Cellular & Molecular ImmunologyH-index: 64

    CiteScore: 31.20
    TRENDS IN IMMUNOLOGYH-index: 209

    CiteScore: 25.10
    JOURNAL OF EXPERIMENTAL MEDICINEH-index: 411

    CiteScore: 26.60
    AUTOIMMUNITY REVIEWSH-index: 103

    CiteScore: 24.70
    BRAIN BEHAVIOR AND IMMUNITYH-index: 127

    CiteScore: 29.60
    JOURNAL OF AUTOIMMUNITYH-index: 101

    CiteScore: 27.90
    學科內最受檢索的期刊 頁面查看次數
    International Immunopharmacology316309
    JOURNAL OF IMMUNOLOGY156694
    Immunity107936
    Cellular & Molecular Immunology107434
    Vaccine104773
    JOURNAL OF EXPERIMENTAL MEDICINE99453
    MICROBIAL PATHOGENESIS94242
    MOLECULAR IMMUNOLOGY91044
    INFLAMMATION89742
    BRAIN BEHAVIOR AND IMMUNITY84729
  •  

    TRANSFUSION MEDICINE AND HEMOTHERAPY TRANSFUSION MEDICINE AND HEMOTHERAPY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [TRANSFUSION MEDICINE AND HEMOTHERAPY] 的評論撰寫評論
作者: 东风谷晋鹏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-11 21:03:57 評論於
Research Focus: Blood transfusion experience sharing: How long does it take to pay after the layout fee is received by this journal? How to pay?
(0) 讚! | 东风谷晋鹏

作者: 削月宛风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-05 14:06:31 評論於
I love the way you laugh, it always makes me smile
(0) 讚! | 削月宛风

作者: Maud Bauer


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-06 19:31:06 評論於
Can I submit a review on the direction of blood transfusion?
(0) 讚! | Maud Bauer

作者: 宜生项睢


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2022-04-26 18:08:54 評論於
Overall, the submission process went smoothly. The editor was very good, and I initially thought that the quarterly journal would be slow, but the speed was actually acceptable. Although the impact factor is not high at the moment, it is still considered a very good journal in the field of transfusion.
(0) 讚! | 宜生项睢

作者: 削月宛风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-24 15:54:36 評論於
Review speed: 3.0 | Submission hit rate: 75.0
Experience sharing: Overall, the submission process was quite smooth. The editors were very good, and I originally thought the quarterly publication would be slow, but it turned out to be quite fast. Although the impact factor is not high at the moment, it is considered a very good journal in the field of transfusion
(0) 讚! | 削月宛风

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 18:09:13 評論於
Authors should first conduct search and analysis in SCI and Scopus databases. Second, they should carefully read the submission guidelines of the journal they are preparing to submit to, and review the recent issues of the journals to confirm if their paper fits with the scope of the journal
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:22:47 評論於
3-5 alternative journals
(0) 讚! | 维尔娜菲茨杰拉德

作者: 破戒阳平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 23:11:06 評論於
How many would you like to choose for publication?
(0) 讚! | 破戒阳平

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 21:34:10 評論於
How to evaluate the impact factor of one's own article, or how to better position one's own article?
(0) 讚! | 上清雨真

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 10:01:16 評論於
It's frustrating that I received over 2 points for my publication last year, but only got just over 1 point this year. Will it decrease even more next year? Who would be willing to submit to it?
(0) 讚! | 凌霄高洁

作者: Susie Jenny


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-08-12 19:25:28 評論於
Submitted an article, rejected a month later, said it was rejected after editors and reviewers considered it, but did not provide any review comments. Not as long as everyone said
(0) 讚! | Susie Jenny

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-08-05 11:10:01 評論於
Review speed: 6.0 | Submission acceptance rate: 5.0
Experience sharing: The review process is too slow! Almost despairing!
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-08-03 20:44:47 評論於
Review speed: 6.0 | Submission hit rate: 25.0 Experience Sharing: Yes, Germans are known for their precision worldwide, and Japanese magazines are also difficult to submit to, as Japanese people are also very meticulous
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-08-02 13:44:25 評論於
The German magazine is still very strict; it was revised three times and ultimately rejected
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-07-30 12:13:41 評論於
Surprise, last year it was just over 1 point, this year it suddenly increased to over 2 points, but reaching 3 points is like crossing a threshold, and it will be easier from now on
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-06-04 19:25:45 評論於
SCI(2010): .824 Trash journal, who cares, submit first, talk later
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-05-20 17:33:26 評論於
Review speed: 6.0
Experience sharing: It's been half a year, still under reviewer, did the editor forget?
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-01-09 19:47:19 評論於
Review speed: 3.0 Experience sharing: Super slow! It has been 2 months and still under reviewer
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 12:25:46 評論於
Trashy magazines, whatever, just go ahead and submit first
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [TRANSFUSION MEDICINE AND HEMOTHERAPY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*